LATEST NEWS

NBTXR3-enhanced proton beam immunoradiotherapy reshapes tumor immune microenvironment and improves abscopal effect in an anti-PD1-resistant lung cancer

For inquiries about our technology, collaborations, clinical trials, or other topics, we encourage you to get in touch with our team.